Hepatitis B Studies

HBsAg/HBV DNA Ratio Emerges as Strong Predictor of Progression in Immune-Tolerant Hepatitis B

A decade-long cohort with external validation reports AUC 0.85, identifying a 1.791 cutoff for sharply rising risk.